Future of Medicine (ENG)

Nanobiomedical materials offer solutions to the greatest biomedical challenges of our time. For example, tracers can be used for novel imaging techniques for early disease detection. Furthermore, nanoscale drug carriers can treat a wide variety of diseases more efficiently and with fewer side effects by activating active substances in a targeted manner through biological, chemical or mechanical mechanisms at the target site.

Many development steps are required to make such therapies and forms of diagnosis possible: In basic research, new nano/biomaterials and drug delivery systems must be developed and tested. If an application is promising, the nanomedicine product must be manufactured and tested intensively first in animal models and later in humans (in phase I – III studies). Such work can only be successfully realised in interdisciplinary teams composed of natural scientists, engineers and physicians. In addition, economic and ethical disciplines are important for successful research in nanobiomedicine.

In this course we would like to give an overview of the most promising research and developments in nanobiomedicine and how molecular technologies open up completely new possibilities for triggerable and tailored activation of pharmaceutical agents.